CN110652481A - Hyaluronic acid mild moisturizing facial cleanser and preparation method thereof - Google Patents
Hyaluronic acid mild moisturizing facial cleanser and preparation method thereof Download PDFInfo
- Publication number
- CN110652481A CN110652481A CN201911047166.8A CN201911047166A CN110652481A CN 110652481 A CN110652481 A CN 110652481A CN 201911047166 A CN201911047166 A CN 201911047166A CN 110652481 A CN110652481 A CN 110652481A
- Authority
- CN
- China
- Prior art keywords
- parts
- phase
- prepared
- skin
- hyaluronic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/342—Alcohols having more than seven atoms in an unbroken chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Cosmetics (AREA)
Abstract
The invention discloses a hyaluronic acid mild moisturizing cleanser and a preparation method thereof, wherein the hyaluronic acid mild moisturizing cleanser is prepared by mixing a phase A, a phase B and a phase C; the phase A is prepared from the following raw materials: deionized water, glycerol, butanediol, sclerotium rolfsii gum, carbomer, hydrolyzed sodium hyaluronate, humectant, panthenol and EDTA disodium; the phase B is prepared from the following raw materials: ethylhexyl palmitate, behenyl alcohol, skin conditioning agents, ethylene glycol distearate, polysorbate-60, polyglyceryl-10 diisostearate, polyglyceryl-10 stearate; the phase C is prepared from the following raw materials: lauryl glucoside solution, lauryl hydroxy sulfobetaine solution, moisturizing antibacterial agent, Gentiana lutea root extract, Cladosiphon okamuranus Dunn polysaccharide and PEG-7 sodium olive oil carboxylate. The hyaluronic acid mild moisturizing facial cleanser disclosed by the invention has the advantages of mildness, no stimulation, good cleaning effect, no tightness of skin after face cleaning, long-acting water locking, moisture retention and melanin precipitation inhibition.
Description
Technical Field
The invention relates to the technical field of skin care products, in particular to hyaluronic acid mild moisturizing facial cleanser and a preparation method thereof.
Background
With the improvement of living standard, people pay more and more attention to the maintenance of facial skin, and the requirements on skin cleaning products are continuously increased. From the traditional pursuit of cleaning, the attention is turned to the mildness and non-irritation to the skin, and the attention is paid to different seasons, such as autumn and winter, different environments, such as low relative humidity of air, and particularly the differentiation of dry cleaning products. For example, in winter, under extreme environmental conditions such as cold temperature and dryness, consumers often desire additional protection of the skin after use of the cleansing product.
In the prior art, soap-based face-cleaning products have a strong cleaning effect, but because the cleaning force is strong, the degreasing property is high, discomfort such as skin tightness and dryness is easy to occur after the face-cleaning products are used, adverse reaction is easy to occur to sensitive skin, and the face-cleaning products are not suitable for being used under the conditions of low temperature, dryness and the like.
In the prior art, a Chinese patent application with the application number of CN201711352414.0 discloses a facial cleanser containing dendrobium officinale extract and a preparation method thereof, wherein the facial cleanser comprises a component A in parts by weight: 30-45 parts of succinate surfactant, 10-25 parts of amino acid surfactant, 5-20 parts of zwitterionic surfactant, 10-30 parts of humectant, 0.1-0.5 part of emulsifier and 1-5 parts of whale vinegar stearyl alcohol; and B component: 0.5-5 parts of sodium chloride and 1-5 parts of deionized water; and C, component C: 0.1-5 parts of thickening agent and 1-5 parts of deionized water; and (D) component: 0.1-5 parts of skin feel regulator and 1-5 parts of deionized water; and E, component (E): 0.1-0.5 part of p-hydroxyacetophenone and 0.1-1 part of 1, 2-hexanediol; and F component: 0.01-1 part of alpine plant extract, 0.01-2 parts of dendrobium officinale extract and 0.01-1 part of ascorbyl palmitate.
The existing facial cleanser uses an amino acid surfactant, has the advantages of being mild and non-irritating, and providing certain care for skin while cleaning skin, is synthesized by taking amino acid and fatty acid as raw materials, belongs to organism components due to renewable raw materials, is easy to biodegrade and low in toxicity, has a pH value of about 5.0-8.0 generally, is close to the pH value of healthy oriental skin, is not dry and tight in skin feeling after washing, and has the defects of insufficient cleaning capacity and insufficient skin moisturizing capacity after use although the irritation to the skin can be reduced.
Therefore, the development of the mild, non-irritant, good-cleaning effect and long-acting water-locking and moisture-keeping facial cleanser is needed.
Disclosure of Invention
Aiming at the defects in the prior art, the first purpose of the invention is to provide the hyaluronic acid mild moisturizing facial cleanser which has the advantages of being mild, free of stimulation, free of skin tightness after washing, good in cleaning effect, and capable of locking water and moisturizing for a long time.
The second purpose of the invention is to provide a preparation method of the hyaluronic acid mild moisturizing facial cleanser, which has the advantages of simple operation and easy realization.
In order to achieve the first object, the invention provides the following technical scheme: a mild moisturizing facial cleanser containing hyaluronic acid is prepared by mixing phase A, phase B and phase C;
the phase A is prepared from the following raw materials in parts by weight: 58-95 parts of deionized water, 2-16 parts of glycerol, 1-10 parts of butanediol, 0.02-0.8 part of sclerotium rolfsii gum, 0.1-1 part of carbomer, 0.02-0.5 part of hydrolyzed sodium hyaluronate, 0.02-0.15 part of humectant, 0.02-0.8 part of panthenol and 0.02-0.06 part of EDTA disodium;
the phase B is prepared from the following raw materials in parts by weight: 2-12 parts of ethylhexyl palmitate, 0.5-2.5 parts of behenyl alcohol, 1-5 parts of skin conditioning agent, 0.5-5 parts of ethylene glycol distearate, 0.05-3 parts of polysorbate-60, 0.5-3 parts of polyglycerol-10 diisostearate and 0.1-3 parts of polyglycerol-10 stearate;
the phase C is prepared from the following raw materials in parts by weight: 4-20 parts of lauryl glucoside solution, 5-20 parts of lauryl hydroxy sulfobetaine solution, 0.5-1.5 parts of moisturizing antibacterial agent, 0.1-2 parts of gentiana lutea root extracting solution, 0.1-1 part of cladosporium cucumerinum polysaccharide and 0.1-5 parts of PEG-7 sodium olive oil carboxylate.
By adopting the technical scheme, as the hydrolyzed sodium hyaluronate is used in the phase A, the hydrolyzed sodium hyaluronate has small molecular weight, can be quickly dissolved and can act on the surface of the skin, and micromolecular hyaluronic acid can permeate into dermis, thereby having the functions of slightly dilating capillary vessels, increasing blood circulation, improving intermediary metabolism and promoting skin nutrition absorption, and has strong wrinkle eliminating ability, can increase skin elasticity, keep moisture for a long time, delay skin aging, promote pulverization of epidermal cell proliferation, clear away oxygen free radicals, inhibit lipid peroxidation lipid, prevent and repair skin injury, adopts scleroglucan and carbomer as thickening agents, can increase the viscosity of the cleanser, is a permeable humectant, can help hydrolyzed sodium hyaluronate permeate into skin, and the water-retaining moisturizing cream covers the skin, absorbs water from the environment, and is used together with glycerin, so that the water-retaining moisturizing effect is improved.
The behenyl alcohol, the polyglycerol-10 stearate, the ethylene glycol distearate and the like in the phase B are used together to form a frame type liquid crystal structure, so that the stability of the facial cleanser is improved, the facial cleanser is convenient to spread on the facial skin under the coordination of the ethylhexyl palmitate with the skin softening function, and the facial cleaning effect is better.
The lauryl glucoside in the C phase has the advantages of mild performance, good foaming effect and strong permeability, and can achieve the mild decontamination effect and enhance the decontamination capability when being used in cooperation with lauryl hydroxy sulfobetaine, and the lauryl hydroxy sulfobetaine has good mildness, so that the lauryl hydroxy sulfobetaine and lauryl hydroxy sulfobetaine have small irritation when being used in cooperation for decontamination, the facial skin is not easy to dry and stretch after the face is cleaned, if the lauryl hydroxy sulfobetaine and lauryl hydroxy sulfobetaine are used in a reduced amount, the cleaning force is insufficient, and if the lauryl hydroxy sulfobetaine and lauryl hydroxysulfobetaine are used in an increased amount, the cleaning force is strong, and the phenomena of tight and dry face are easy to; because the gentiana lutea root extracting solution has the effects of inhibiting melanin deposition, improving whitening and reducing irritation caused by a surfactant, the gentiana lutea polysaccharide has the effects of fading fine wrinkles, improving skin elasticity and long-acting water locking and moisture preserving, has good permeability, can carry the gentiana lutea root extracting solution to quickly permeate to the stratum corneum and accelerate the absorption of effective components, so that the skin keeps moist, glossy and active for a long time, and the gentiana lutea root extracting solution and the gentiana lutea polysaccharide are cooperatively used, so that the mild decontamination can be realized, the water locking and moisture preserving effect of the face can be improved, the fine wrinkles can be faded, the melanin deposition can be inhibited, if the two using amounts are reduced, the effect of inhibiting the irritation of the surfactant is reduced, the allergy phenomenon is easy to occur, when the two using amounts are increased, the antioxidant effect of the facial cleanser is increased, and the dry and tight phenomenon of the face is easy to occur.
Further, the phase A is prepared from the following raw materials in parts by weight: 65-80 parts of deionized water, 6-12 parts of glycerol, 3-7 parts of butanediol, 0.1-0.6 part of sclerotium rolfsii gum, 0.3-0.6 part of carbomer, 0.1-0.4 part of hydrolyzed sodium hyaluronate, 0.03-0.1 part of humectant, 0.1-0.6 part of panthenol and 0.03-0.06 part of EDTA disodium;
the phase B is prepared from the following raw materials in parts by weight: 4-10 parts of ethylhexyl palmitate, 1-2 parts of behenyl alcohol, 1.8-3 parts of a skin conditioning agent, 1-3 parts of ethylene glycol distearate, 0.1-2 parts of polysorbate-60, 1-2 parts of polyglycerol-10 diisostearate and 0.5-2 parts of polyglycerol-10 stearate;
the phase C is prepared from the following raw materials in parts by weight: 8-17 parts of lauryl glucoside solution, 8-17 parts of lauryl hydroxy sulfobetaine solution, 0.7-1.3 parts of moisturizing antibacterial agent, 0.5-1.5 parts of gentiana lutea root extract, 0.3-0.9 part of cladosporium cucumerinum polysaccharide and 0.5-3 parts of PEG-7 sodium olive oil carboxylate.
By adopting the technical scheme, because the dosage of each substance in each phase is more accurate, the prepared facial cleanser has more excellent long-acting moisturizing and water locking effects, and the effects of fading fine lines and brightening skin are more obvious.
Further, in the phase C, the lauryl glucoside liquid is prepared by mixing lauryl glucoside and water in a mass ratio of 4.5-5.5: 4.5-5.5;
the lauryl hydroxy sulfobetaine solution comprises, by weight, 28-30 parts of lauryl hydroxy sulfobetaine, 6-8 parts of sodium chloride and 62-76 parts of water.
By adopting the technical scheme, the lauryl glucoside has the advantages of low surface tension, mild performance, excellent foaming and wetting performances, mild to human body, strong permeability, good compatibility of lauryl hydroxysulfobetaine, excellent thickening property, flexibility, bactericidal property and hard water resistance, and can obviously improve the softness and the mildness of the facial cleanser.
Further, in the phase C, the gentiana lutea root extracting solution comprises 72-76 parts of water, 24-26 parts of butanediol and 1-4 parts of gentiana lutea root extract in parts by weight.
By adopting the technical scheme, the Gentiana lutea root extract has efficient anti-inflammatory and antibacterial effects, can inhibit melanin pigmentation, enables the skin to maintain a natural whitening state, simultaneously reduces stimulation caused by a surfactant, enables the facial cleanser to be mild, and is suitable for any skin-type people including allergic skin;
further, in the phase C, the cladosporium fortunei polysaccharide comprises 0.3-0.6 part of cladosporium fortunei extract, 24-27 parts of phenoxyethanol and 72.4-75.7 parts of water in parts by weight.
By adopting the technical scheme, the cladosporium asteroides extract can repair skin barriers, enable the skin to be moist and smooth, nourish the skin, and has the effects of long-acting moisture retention, allergy resistance, cell activity activation, oxidation resistance and the like.
Furthermore, in the phase A, the humectant is prepared by mixing 68-72 parts of octyl glycol and 28-32 parts of ethylhexyl glycerin in parts by weight.
By adopting the technical scheme, the caprylyl glycol has good moisturizing effect and bacteriostatic function, can adjust the humidity of the skin, has the effects of moistening, softening and moistening, and being mild and antiseptic, and the ethylhexyl glycerin is a multifunctional humectant, can also play a bacteriostatic role, is matched with the caprylyl glycol for use, and can improve the antibacterial effect of the caprylyl glycol.
Further, in the phase B, the skin conditioning agent comprises 80-84 parts of dioctyl lauryl glutamate and 16-20 parts of whale vinegar stearyl alcohol in parts by weight.
By adopting the technical scheme, the whale vinegar stearyl alcohol has excellent effects of moistening skin and removing grease, is fresh and cool and not greasy, and is quick in response speed, stable dispersion solution can be formed in a system by using the whale vinegar stearyl alcohol and the dioctyl lauryl glutamic acid ester together, the moisturizing cream has a good moisturizing effect on skin, the capability of absorbing moisture of the skin stratum corneum can be enhanced, the irritation of the product is reduced, and the cleansing cream is mild and not irritant.
Further, in the phase C, the moisturizing antibacterial agent comprises 15-20 parts by weight of glyceryl caprylate, 74-81.5 parts by weight of 1, 2-pentanediol and 3.5-6 parts by weight of caprylhydroxamic acid.
By adopting the technical scheme, short lipophilic carbon chains in the glyceryl caprylate can permeate into and be adsorbed on the lipid part of the facial skin, so that a better moisturizing effect can be formed on the stratum corneum part, the glyceryl caprylate also has an antibacterial effect, the service life of the facial cleanser is prolonged, the caprylyl hydroximic acid and the 1, 2-pentanediol have excellent antibacterial and bacteriostatic properties, the moisturizing antibacterial agent prepared by mixing the three can improve the water locking and moisturizing effects of the facial cleanser, and the facial cleanser is prevented from breeding bacteria and influencing the use.
In order to achieve the second object, the invention provides the following technical scheme: a preparation method of hyaluronic acid mild moisturizing cleanser comprises the following steps:
s1, mixing the components in the phase A, heating to 78-80 ℃, stirring until the components are completely dissolved, and homogenizing in a homogenizer for 3-10min to obtain a phase A treatment material;
s2, mixing the raw materials in the phase B, heating to 78-85 ℃, and uniformly mixing and stirring to obtain a phase B treatment material;
s3, mixing the phase A treatment material and the phase B treatment material, homogenizing at high speed for 5-8min, keeping the temperature at 78-80 ℃, stirring for 13-15min, stirring and cooling to 60 ℃, adding the mixture of each component in the phase C, and homogenizing for 10-15min to uniformly mix the materials;
and S4, continuously stirring and cooling, vacuumizing simultaneously, and discharging when the temperature is reduced to 37 ℃ to prepare the hyaluronic acid mild moisturizing facial cleanser.
Further, the high-speed homogenizing rotation speed of the phase A treated material and the phase B treated material in the step S3 is 500-.
In conclusion, the invention has the following beneficial effects:
firstly, as the invention adopts hydrolyzed sodium hyaluronate as the phase A raw material and is matched with permeable humectant panthenol, under the action of the panthenol, the hydrolyzed sodium hyaluronate can quickly permeate to the skin, so as to slightly expand blood vessels, increase blood circulation, promote the absorption of nutrient components, remove oxygen free radicals, delay aging and improve the elasticity of the skin, and the panthenol can be attached to the skin and absorb moisture from the environment, and can be used together with glycerin to prevent the panthenol from sucking the moisture from the deep part of the skin, thereby moisturizing the moisture content of the facial skin, increasing the moisturizing degree of the skin and enabling the skin to be moisturized and elastic.
Secondly, the behenyl alcohol, the polyglycerol-10 stearate, the ethylhexyl palmitate and the like are preferably used as the phase B raw materials, the ethylhexyl palmitate has the functions of softening and softening the skin, the behenyl alcohol and the polyglycerol-10 stearate can form a frame type liquid crystal structure, the stability of the facial cleanser is improved, and the multiple components are used cooperatively, so that the facial cleanser can be conveniently spread and foamed on the skin, the facial cleaning effect is good, and the decontamination effect is strong.
Thirdly, the gentiana lutea root extracting solution and the cladosporium cucumerinum polysaccharide are used in a matched mode in the phase C, the gentiana lutea root extracting solution can reduce the irritation of a surfactant to the face, melanin precipitation can be inhibited, the brightness of the skin is improved, the cladosporium cucumerinum polysaccharide can improve the elasticity and long-acting water locking and moisture retention of the skin, and the cladosporium cucumerinum polysaccharide can carry the gentiana lutea root extracting solution to quickly permeate into the stratum corneum to accelerate the absorption of effective components, so that the skin can keep moist and glossy.
And fourthly, in the phase C of the invention, lauryl glucoside and lauryl hydroxy sulfobetaine are used cooperatively, so that the effects of mild decontamination, enhanced decontamination capability and reduced irritation can be achieved, and the facial skin of the facial cleanser is not dry, tight and moist and elastic after being cleaned.
Detailed Description
The present invention will be described in further detail with reference to examples.
Examples
Examples 1-6 where the hydrolyzed sodium hyaluronate was selected from water-based sodium hyaluronate with a molecular weight of less than 5000Da sold by cantonese gay biotechnology limited, scleroglucan was selected from sbackacac, and carbomer was selected from luoborun.
Example 1: the hyaluronic acid mild moisturizing facial cleanser is prepared by mixing a phase A, a phase B and a phase C, and the preparation method of the hyaluronic acid mild moisturizing facial cleanser comprises the following steps:
s1, mixing the components in the phase A, heating to 80 ℃, stirring until the components are completely dissolved, and homogenizing in a homogenizer for 3min to obtain a phase A treatment material;
the raw material formula of each component in the phase A is shown in Table 1, and comprises 58kg of deionized water, 2kg of glycerol, 1kg of butanediol, 0.02kg of sclerotium rolfsii gum, 0.1kg of carbomer, 0.02kg of hydrolyzed sodium hyaluronate, 0.01kg of humectant, 0.02kg of panthenol and 0.02kg of disodium EDTA, wherein the humectant is prepared by mixing 68kg of caprylyl glycol and 32kg of ethylhexyl glycerol;
s2, mixing the raw materials in the phase B, heating to 85 ℃, and uniformly mixing and stirring to obtain a phase B treatment material;
wherein the raw material formula of each component in the B phase is shown in Table 1, and comprises 2kg of ethylhexyl palmitate, 0.5kg of behenyl alcohol, 1kg of skin conditioning agent, 0.5kg of ethylene glycol distearate, 0.05kg of polysorbate-60, 0.5kg of polyglycerin-10 diisostearate and 0.1kg of polyglycerin-10 stearate, wherein the skin conditioning agent is prepared by mixing 80kg of dioctyldodecanol lauroyl glutamate and 20kg of whale vinegar stearyl alcohol;
s3, mixing the phase A treatment material and the phase B treatment material, homogenizing at high speed for 8min, keeping the temperature at 80 ℃ and stirring for 13min, adding the mixture of the components in the phase C when stirring and cooling to 60 ℃, and homogenizing for 10min to uniformly mix the materials;
wherein the raw material formula of each component in the C phase is shown in Table 1, and comprises 4kg of lauryl glucoside liquid, 5kg of lauryl hydroxy sulfobetaine solution, 0.5kg of moisturizing antibacterial agent, 0.1kg of Gentiana lutea root extracting solution, 0.1kg of Cladosiphon okamuranus polysaccharide and 0.1kg of PEG-7 sodium olive oil carboxylate, wherein the ratio of the mass of the lauryl glucoside liquid to the mass of the lauryl glucoside liquid is 4.5: 5.5 by mixing lauryl glucoside with water, the lauryl hydroxysulfobetaine solution comprising 28kg lauryl hydroxysulfobetaine, 6kg sodium chloride and 62kg water, the moisturizing antibacterial agent comprising 20kg glyceryl caprylate, 74kg 1, 2-pentanediol and 6kg caprylyl hydroxamic acid, the Gentiana lutea root extract comprising 72kg water, 26kg butanediol and 2kg Gentiana lutea root extract, the starfish ramaria polysaccharide comprising 0.3kg, 24kg phenoxyethanol and 75.7kg water;
and S4, continuously stirring and cooling, vacuumizing simultaneously, and discharging when the temperature is reduced to 37 ℃ to prepare the hyaluronic acid mild moisturizing facial cleanser.
TABLE 1 raw material ratios of phase A, phase B and phase C in examples 1-7
Example 2: the hyaluronic acid mild moisturizing facial cleanser is prepared by mixing a phase A, a phase B and a phase C, and the preparation method of the hyaluronic acid mild moisturizing facial cleanser comprises the following steps:
s1, mixing the components in the phase A, heating to 79 ℃, stirring until the components are completely dissolved, and homogenizing in a homogenizer for 4min to obtain a phase A treatment material;
the raw material formula of each component in the phase A is shown in Table 1, and comprises 65kg of deionized water, 6kg of glycerol, 5kg of butanediol, 0.1kg of sclerotium rolfsii gum, 0.3kg of carbomer, 0.2kg of hydrolyzed sodium hyaluronate, 0.03kg of humectant, 0.1kg of panthenol and 0.03kg of disodium EDTA, wherein the humectant is prepared by mixing 72kg of caprylyl glycol and 28kg of ethylhexyl glycol;
s2, mixing the raw materials in the phase B, heating to 82 ℃, and uniformly mixing and stirring to obtain a phase B treatment material;
wherein the raw material formula of each component in the phase B is shown in Table 1, and comprises 4kg of ethylhexyl palmitate, 1kg of behenyl alcohol, 2kg of skin conditioning agent, 1kg of ethylene glycol distearate, 0.1kg of polysorbate-60, 0.8kg of polyglycerin-10 diisostearate and 0.8kg of polyglycerin-10 stearate, wherein the skin conditioning agent is prepared by mixing 84kg of dioctyl lauryl glutamate and 16kg of whale vinegar stearyl alcohol;
s3, mixing the phase A treatment material and the phase B treatment material, homogenizing at high speed for 6min, keeping the temperature at 79 ℃ and stirring for 14min, adding the mixture of the components in the phase C when stirring and cooling to 60 ℃, and homogenizing for 12min to uniformly mix the materials;
wherein the raw material formula of each component in the C phase is shown in Table 1, and comprises 8kg of lauryl glucoside liquid, 8kg of lauryl hydroxy sulfobetaine solution, 0.7kg of moisturizing antibacterial agent, 0.8kg of Gentiana lutea root extracting solution, 0.3kg of Cladosiphon okamuranus polysaccharide and 0.5kg of PEG-7 sodium olive oil carboxylate, wherein the ratio of the mass of the lauryl glucoside liquid to the mass of the lauryl glucoside liquid is 5.5:4.5 of lauryl glucoside and water, the lauryl hydroxysulfobetaine solution comprises 29kg of lauryl hydroxysulfobetaine, 7kg of sodium chloride and 64kg of water, the moisturizing antibacterial agent is prepared by mixing 18kg of glyceryl caprylate, 77.5kg of 1, 2-pentanediol and 5.5kg of caprylyl hydroxamic acid, the gentiana lutea root extract is prepared by mixing 72kg of water, 24kg of butanediol and 4kg of gentiana lutea root extract, and the starfish ramaria polysaccharide is prepared by mixing 0.6kg of phenoxyethanol, 27kg of phenoxyethanol and 72.4kg of water;
and S4, continuously stirring and cooling, vacuumizing simultaneously, and discharging when the temperature is reduced to 37 ℃ to prepare the hyaluronic acid mild moisturizing facial cleanser.
Example 3: the hyaluronic acid mild moisturizing facial cleanser is prepared by mixing a phase A, a phase B and a phase C, and the preparation method of the hyaluronic acid mild moisturizing facial cleanser comprises the following steps:
s1, mixing the components in the phase A, heating to 78 ℃, stirring until the components are completely dissolved, and homogenizing in a homogenizer for 5min to obtain a phase A treatment material;
the raw material formula of each component in the phase A is shown in Table 1, and comprises 75kg of deionized water, 10kg of glycerol, 3kg of butanediol, 0.2kg of sclerotium rolfsii gum, 0.5kg of carbomer, 0.1kg of hydrolyzed sodium hyaluronate, 0.05kg of humectant, 0.2kg of panthenol and 0.05kg of disodium EDTA, wherein the humectant is prepared by mixing 70kg of caprylyl glycol and 30kg of ethylhexyl glycerol;
s2, mixing the raw materials in the phase B, heating to 78 ℃, and uniformly mixing and stirring to obtain a phase B treatment material;
wherein the raw material formula of each component in the B phase is shown in Table 1, and comprises 8kg of ethylhexyl palmitate, 2kg of behenyl alcohol, 1.8kg of skin conditioning agent, 1.5kg of ethylene glycol distearate, 0.3kg of polysorbate-60, 1.5kg of polyglycerol-10 diisostearate and 0.5kg of polyglycerol-10 stearate, wherein the skin conditioning agent is prepared by mixing 82kg of dioctyl lauryl glutamate and 18kg of whale vinegar stearyl alcohol;
s3, mixing the phase A treatment material and the phase B treatment material, homogenizing at high speed for 5min at 2500r/min, keeping the temperature at 78 ℃ and stirring for 15min, stirring and cooling to 60 ℃, adding the mixture of the components in the phase C, and homogenizing for 15min to uniformly mix the materials;
wherein the raw material formula of each component in the phase C is shown in Table 1 and comprises 12kg of lauryl glucoside liquid, 10kg of lauryl hydroxysulfobetaine liquid, 0.9kg of moisturizing antibacterial agent, 0.5kg of Gentiana lutea root extracting liquid, 0.5kg of Cladosiphon okamuranus Dunn polysaccharide and 1kg of sodium PEG-7 olive oil carboxylate, the lauryl glucoside liquid is prepared by mixing lauryl glucoside and water in a mass ratio of 5:5, the lauryl hydroxysulfobetaine liquid comprises 30kg of lauryl hydroxysulfobetaine, 8kg of sodium chloride and 62kg of water, the moisturizing antibacterial agent is prepared by mixing 15kg of glyceryl caprylate, 82.5kg of 1, 2-pentanediol and 3.5kg of caprylyl hydroxamic acid, the Gentiana lutea root extracting liquid is prepared by mixing 74kg of water, 25kg of butanediol and 1kg of Gentiana lutea root extract, and the Gentiana asteroidea Branch polysaccharide is prepared by mixing 0.5kg of ethanol and 74.5kg of water;
and S4, continuously stirring and cooling, vacuumizing simultaneously, and discharging when the temperature is reduced to 37 ℃ to prepare the hyaluronic acid mild moisturizing facial cleanser.
Example 4: a sodium hyaluronate mild moisturizing cleanser is different from example 3 in that the formula of raw materials of phase A, phase B and phase C is shown in Table 1, wherein a moisturizing agent in phase A is prepared by mixing 69kg of caprylyl glycol and 31kg of ethylhexyl glycerin; the skin conditioner in phase B is prepared by mixing 83kg dioctyl lauryl glutamate and 17kg whale vinegar stearyl alcohol; the lauryl glucoside liquid in the C phase is prepared by mixing lauryl glucoside and water in a mass ratio of 4.8:5.2, the lauryl hydroxy sulfobetaine solution comprises 29kg of lauryl hydroxy sulfobetaine, 6kg of sodium chloride and 65kg of water, the moisturizing antibacterial agent is prepared by mixing 17kg of glyceryl caprylate, 79kg of 1, 2-pentanediol and 4kg of caprylyl hydroxamic acid, the gentiana lutea root extracting solution is prepared by mixing 73kg of water, 26kg of butanediol and 1kg of gentiana lutea root extract, and the starfish ramaria polysaccharide is prepared by mixing 0.4kg of phenoxyethanol, 24kg of phenoxyethanol and 75.6kg of water.
Example 5: a sodium hyaluronate mild moisturizing cleanser is different from example 3 in that the raw material formula of phase A, phase B and phase C is shown in Table 1, wherein the moisturizing agent in phase A is prepared by mixing 71kg of caprylyl glycol and 29kg of ethylhexyl glycol; the skin conditioner in phase B is prepared by mixing 81kg dioctyl lauryl glutamate and 19kg whale vinegar stearyl alcohol; the lauryl glucoside liquid in the C phase is prepared by mixing lauryl glucoside and water in a mass ratio of 5.2:4.8, the lauryl hydroxy sulfobetaine solution comprises 29kg of lauryl hydroxy sulfobetaine, 8kg of sodium chloride and 63kg of water, the moisturizing antibacterial agent is prepared by mixing 19kg of glyceryl caprylate, 75.5kg of 1, 2-pentanediol and 5.5kg of caprylyl hydroxamic acid, the gentiana lutea root extracting solution is prepared by mixing 75kg of water, 24kg of butanediol and 1kg of gentiana lutea root extract, and the starfish ramaria polysaccharide is prepared by mixing 0.5kg of phenoxyethanol and 73.5kg of water.
Example 6: a sodium hyaluronate mild moisturizing cleanser is different from the cleanser in example 3 in that the raw material formulation of phase A, phase B and phase C is shown in Table 1, wherein the moisturizing agent in phase A is prepared by mixing 70kg of caprylyl glycol and 30kg of ethylhexyl glycerin; the skin conditioner in phase B is prepared by mixing 82kg dioctyl lauryl glutamate and 18kg whale vinegar stearyl alcohol; the lauryl glucoside liquid in the C phase is prepared by mixing lauryl glucoside and water in a mass ratio of 5:5, the lauryl hydroxysulfobetaine solution comprises 30kg of lauryl hydroxysulfobetaine, 8kg of sodium chloride and 62kg of water, the moisturizing antibacterial agent is prepared by mixing 15kg of glyceryl caprylate, 82.5kg of 1, 2-pentanediol and 3.5kg of caprylyl hydroximic acid, the gentiana lutea root extracting solution is prepared by mixing 74kg of water, 25kg of butanediol and 1kg of gentiana lutea root extract, and the starfish ramus polysaccharide is prepared by mixing 0.5kg of phenoxyethanol and 74.5kg of water.
Comparative example
Comparative example 1: a sodium hyaluronate mild moisturizing cleanser, which is different from example 3 in that lauryl glucoside solution and lauryl hydroxysulfobetaine solution are not added to phase C.
Comparative example 2: a sodium hyaluronate mild moisturizing cleanser is different from the cleanser in example 3 in that lauryl glucoside solution is used in an amount of 3kg and lauryl hydroxysulfobetaine solution is used in an amount of 4kg in the C phase.
Comparative example 3: a sodium hyaluronate mild moisturizing cleanser is different from the cleanser in example 3 in that the dosage of lauryl glucoside liquid in the C phase is 21kg, and the dosage of lauryl hydroxy sulfobetaine solution is 21 kg.
Comparative example 4: a sodium hyaluronate mild moisturizing cleanser is different from the cleanser in example 3 in that no cladosporium asteroides polysaccharide and gentiana lutea root extract are added in the phase C.
Comparative example 5: a sodium hyaluronate mild moisturizing cleanser is different from the cleanser in example 3 in that the content of Cladosiphon okamuranus polysaccharide in the C phase is 0.05kg, and the content of Gentiana lutea root extract is 0.05 kg.
Comparative example 6: a sodium hyaluronate mild moisturizing cleanser is different from the cleanser in example 3 in that the content of Cladosiphon okamuranus polysaccharide in the C phase is 1.5kg, and the content of Gentiana lutea root extract is 2.5 kg.
Comparative example 7: a sodium hyaluronate mild moisturizing cleanser, which is different from the cleanser in the embodiment 3 in that no behenyl alcohol and polyglycerol-10 stearate are added in the phase B.
Comparative example 8: a sodium hyaluronate mild moisturizing cleanser, which is different from the cleanser in example 3 in that hydrolyzed sodium hyaluronate is not added to phase a.
Comparative example 9: a sodium hyaluronate mild moisturizing cleanser, which is different from example 3 in that the amount of hydrolyzed sodium hyaluronate used in phase a is 0.01 kg.
Comparative example 10: a sodium hyaluronate mild moisturizing cleanser, which is different from example 3 in that the amount of hydrolyzed sodium hyaluronate used in phase a is 0.6 kg.
Comparative example 11: taking the facial cleanser containing dendrobium officinale extract prepared in example 1 of the chinese invention patent application with the application number of CN201711352414.0 as a control, the facial cleanser specifically comprises the following components in parts by weight: 30-45 parts of succinate surfactant, 10-25 parts of amino acid surfactant, 5-20 parts of zwitterionic surfactant, 10-30 parts of humectant, 0.1-0.5 part of skin regulator and 1-5 parts of spermaceti whale vinegar stearyl alcohol; and B component: 0.5-5 parts of sodium chloride and 1-5 parts of deionized water; and C, component C: 0.1-5 parts of thickening agent and 1-5 parts of deionized water; and (D) component: 0.1-5 parts of skin feel regulator and 1-5 parts of deionized water; and E, component (E): 0.1-0.5 part of p-hydroxyacetophenone and 0.1-1 part of 1, 2-hexanediol; and F component: 0.01-1 part of alpine plant extract, 0.01-2 parts of dendrobium officinale extract and 0.01-1 part of ascorbyl palmitate.
Performance test
Firstly, product safety performance evaluation
1. The test substance: examples 1 to 6 and comparative examples 1 to 11 were used to prepare face cleansers;
2. subject: 170 people in total, all female, age 25-35 years, accord with the volunteer selection standard of the subject, and are randomly divided into 17 groups of 10 people each;
3. the spot test method comprises the following steps: selecting a qualified spot tester, applying about 0.02-0.025 mL of the essence cream prepared in the examples 1-6 to the curved side of the forearm of the subjects in the spot tester by a closed class test method, externally applying a special adhesive tape to the curved side of the forearm of the subjects in the groups 1-6, removing the subject after 24 hours, observing skin reaction 30 minutes after the spot tester of the subject is removed, recording the result according to the skin reaction grading standard in the cosmetic hygiene Specification (2007 edition), applying the facial cleanser prepared in the comparative examples 1-11 to the curved side of the forearm of the subjects in the groups 7-17 by the same operation method, and recording the reaction result in the table 3 according to the skin adverse reaction grading standard in the table 2.
TABLE 2 grading Standard of adverse skin reactions
TABLE 3 results of the spot test on human skin of the face cleansers prepared in examples 1 to 6 and comparative examples 1 to 11
As can be seen from the data in table 3, after the mild moisturizing facial cleanser prepared in examples 1 to 6 of the present invention is applied to the curved side of the arm, the skin reactions of the tested volunteers are all negative, the grade is 0, and the mild moisturizing facial cleanser prepared in examples 1 to 6 has no adverse reaction on the skin of the human body according to the judgment standard of the skin spot test of the human body in the cosmetic hygiene standard (2007 edition).
Compared example 1, because the lauryl glucoside solution and the lauryl hydroxy sulfobetaine alkali are not added in the phase C, the lauryl glucoside solution and the lauryl hydroxy sulfobetaine alkali are not added in the compared example 2, the mild performance of the facial cleanser prepared in the compared examples 1-2 is reduced, the irritation is increased, because the gentiana lutea root extracting solution and the cladosporium polysaccharum polysaccharide are not added in the compared example 4, because the gentiana lutea root extracting solution and the cladosporium polysaccharum polysaccharide are not added in the phase C, the antibacterial and anti-inflammatory effect is reduced in the compared example 5, the irritation caused by the surfactant is difficult to relieve, the irritation of the facial cleanser is expected to be increased, the skin is easy to generate erythema, and after the facial cleansers prepared in the other compared examples are smeared, the tested volunteers have no phenomena of edema, erythema and the like, the skin reactions are all negative, and the facial cleanser is milder, non-.
Second, long-acting water-locking and moisture-keeping effect test
170 female volunteers of 20-30 years old and dry skin were selected and randomly divided into 17 groups of 10 persons each, and 170 volunteers were acclimatized at room temperature of (23 + -1) ° c and humidity of (50 + -5)% for 30min before the test, and skin water content was measured using a corneometer CM825 test probe, wherein 6 groups of volunteers used the face cleansers prepared in examples 1-6, respectively, the remaining 11 groups used the face cleansers prepared in comparative examples 1-11, and the corneometer CM825 test probe was used to measure the water content of the stratum corneum of the volunteer's face once after 1h, 2h, and 3h, respectively, and the elasticity index R2 of the fixed region was measured using a skin elasticity tester MPA580 (germany CK), and the measurement results are shown in table 4.
Table 4 long-acting water-retaining and moisturizing effect test of facial cleansers prepared in examples 1 to 6 and comparative examples 1 to 11
As can be seen from the data in table 4, the mild moisturizing facial cleanser prepared in embodiments 1 to 7 of the present invention has the advantages of high facial moisture content and obvious moisturizing effect after 1 hour of facial cleansing, and has strong water locking and heat preserving effects after 2 to 3 hours of facial cleansing, so that the skin is not dry, the water locking effect is strong, the facial moisture is not easy to run off, the skin is kept moist and not tight for a long time, the skin elasticity is obviously increased, the stratum corneum can be repaired, and the skin is protected.
Comparative example 1 since lauryl glucoside solution and lauryl hydroxysultaine solution were not added to phase C, comparative example 2 As the amounts of lauryl glucoside solution and lauryl hydroxysulfobetaine solution used in phase C were decreased, it was found from the results that the facial cleanser prepared in comparative example 1 had a decreased water-holding and moisture-retaining ability on the facial skin as compared with examples 1 to 6, the facial cleanser prepared in comparative example 2 has increased water-holding and moisturizing abilities as compared to those of comparative example 1, but the effect is inferior to those of the facial cleansers of examples 1 to 6, comparative example 3 since the amounts of lauryl glucoside solution and lauryl hydroxysultaine solution in phase C were increased, the cleaning ability was strong, the moisturizing ability of the face is reduced, the face is easy to dry and stretch, and the water content is low, which shows that the water locking and moisturizing ability of the facial cleanser can be improved by adding the lauryl glucoside solution and the lauryl hydroxysulfobetaine solution with the specified dosage into the facial cleanser.
In comparative example 4, as the cladosporium cucumerinum polysaccharide and the gentiana lutea root extracting solution are not added in the phase C, the detection result shows that the moisture content of the face is 51.6% 1 hour after face cleaning, the moisture content is reduced to 43.7% after 1 hour, and the moisture content of the face is 39.2% after 1 hour, which is not much different from the moisture content of the face before cleaning and the elasticity is not obviously increased, which indicates that the cladosporium cucumerinum polysaccharide and the gentiana lutea root extracting solution are added in the facial cleanser, so that the moisture content and the elasticity of the face skin can be improved after the face skin is cleaned, and the skin has elasticity after long-time water moistening.
The comparative example 5 is that the dosage of the cladosporium polysaccharide and the gentiana lutea root extracting solution in the C phase is reduced, and the moisturizing, water locking and moisture preserving effects of the facial cleanser are reduced, and the comparative example 6 is that the dosage of the cladosporium polysaccharide and the gentiana lutea root extracting solution is increased, so that the antioxidant effect is improved, the moisture preserving and water locking effects of the facial cleanser are reduced, and the phenomenon of dryness and tightness is easy to occur.
Comparative example 7 since no behenyl alcohol and polyglycerin-10 stearate were added to phase B, the spreadability of the cleanser on the face was poor, and after the cleanser prepared in comparative example 3 was used to clean the skin of the face, although the cleansing cleanser had the water-locking and moisturizing effects, the effects were not as prominent as those of the cleansers of examples 1 to 6, and the elasticity increased very slowly, indicating that the incorporation of behenyl alcohol and polyglycerin-10 stearate into the cleanser could increase the degree of facial moisturization and improve the elasticity of the skin.
In comparative example 8, as the hydrolyzed sodium hyaluronate is not added in the phase A, the water content of the skin is increased after the skin is cleaned, but after 3 hours, the water content is only 38.9%, the water locking and moisturizing effect is poor, and the elasticity is slowly increased, which indicates that the water locking and moisturizing effect of the facial cleanser can be improved by adding the hydrolyzed sodium hyaluronate.
Compared with the examples 1-6, the water retention and moisture retention capacity of the facial cleanser is not obviously increased due to the fact that the dosage of the hydrolyzed sodium hyaluronate is reduced in the comparative example 9, the water retention and moisture retention capacity of the facial cleanser to skin is reduced, and the elasticity is slowly increased due to the fact that the dosage of the hydrolyzed sodium hyaluronate is too large in the comparative example 10, so that the water retention and moisture retention capacity of the facial cleanser can be improved due to the fact that the hydrolyzed sodium hyaluronate of the facial cleanser is required to be within the specified dosage of the facial cleanser.
Comparative example 11 is a facial cleanser prepared in the prior art, and the facial cleansers prepared in examples 1 to 6 of the present invention have excellent long-acting moisturizing effect and skin elasticity improving effect by comparing the moisturizing effect and the elasticity increase.
Third, detection of decontamination and whitening effect
1. And (3) testing the decontamination effect: selecting 170 female volunteers aged 20-30 years, 85 of which are oily skin subjects and 85 of which are dry skin subjects, randomly dividing 170 volunteers into 17 groups of 10 persons each, wherein 5 oily skin subjects and 5 dry skin subjects, using forehead and bilateral nasal wings as test areas, applying the facial cleanser prepared in examples 1-6 to 1-6 groups of volunteers and the facial cleanser prepared in comparative examples 1-11 to 7-17 groups of volunteers, and using the method: the preparation is applied for 1 time in the morning and evening, and continuously for 30 days, and when in use, a small amount of water is mixed with the face cleanser, and the mixture is gently kneaded until the mixture is uniformly mixed, and then the mixture is coated to a designated area; skin oil content before and after using the cleanser was measured using the CBS skin test analysis system (CBS-1900) of tai-late borescope, and the skin oil removal rate, which is (skin oil content before use-skin oil content after use)/skin oil content before use × 100%, was calculated according to the following formula to evaluate the cleansing effect of the product, and the measurement results are recorded in table 5;
2. 170 female volunteers aged 18-50 years are selected and randomly divided into 17 groups of 10 persons, and the volunteers in each group are respectively cleaned in the morning and at night and are respectively cleaned in the morning and at night, the facial cleansers prepared in examples 1 to 6 and comparative examples 1 to 11 were applied to the face, continuously used for 30 days, under the environment of the ambient temperature of 25 plus or minus 4 ℃ and the relative humidity of 48 plus or minus 5 percent RH, a MEXAMETER MX16 skin pigment analyzer is adopted, the melanin contents of the facial skin of the volunteers were measured 1 day before the use of the product and 30 days after the continuous use (average value per group), and the melanin inhibition rate (black pigment content 1 day before the use-melanin content 30 days after the use)/melanin content 1 before the use x 100%, and the melanin inhibition rates obtained by the tests of the face cleansers prepared in examples 1 to 6 and comparative examples 1 to 11 were as shown in table 5.
Table 5 stain removal and whitening effect test of the facial cleansers prepared in examples 1 to 6 and comparative examples 1 to 11
As the oil secretion of dry skin is less, it can be seen from the data in table 5 that the cleansing cream prepared according to the method in examples 1 to 6 has a small cleansing power for dry skin, which indicates that the cleansing cream prepared according to examples 1 to 6 of the present invention does not excessively remove the oil of dry skin, does not harm skin, has a strong cleansing power for oily skin, can remove excessive oil secreted on the skin surface of a user with oily skin, and has a good melanin inhibiting effect, can inhibit the yellow and dark complexion of the face, prevent melanin deposition, improve complexion, and have a good whitening effect.
Comparative example 1 since lauryl glucoside solution and lauryl hydroxysulfobetaine solution were not added to phase C, it can be seen from the data in table 5 that the cleansing effect of the cleansing cream prepared in comparative example 1 was reduced regardless of dry skin or oily skin, indicating that the cleansing cream could improve the cleansing power of the cleansing cream on oily skin and dry skin by the synergistic use of lauryl glucoside solution and lauryl hydroxysulfobetaine solution.
Comparative example 2 because the dosage of lauryl glucoside liquid and lauryl hydroxy sulfobetaine solution in the C phase is reduced, compared with the detection result of comparative example 1, the cleaning power of the comparative example 2 on dry skin and oily skin is increased, but the effect is not as good as that of examples 1-6 of the invention, and the dosage of lauryl glucoside liquid and lauryl hydroxy sulfobetaine solution in the C phase is obviously increased, so that the cleaning power of the facial cleanser on dry skin and oily skin is higher, the skin is easy to dry and stretch, and the water content is reduced, which shows that the dosage of lauryl glucoside liquid and lauryl hydroxy sulfobetaine solution in the facial cleansers prepared in examples 1-6 of the invention can effectively control the cleaning power on the faces of people with different skin types within the dosage specified by the invention, and the facial water is not tight.
Comparative example 4, the starfish branch and tube polysaccharide and the radix gentianae lutescens extract are not added in the phase C, the cleansing cream prepared in comparative example 4 has a slightly different decontamination effect on dry skin and oily skin from examples 1-6, but has a small melanin inhibition rate and a poor whitening and skin brightening effect, and comparative example 5, the dosage of the starfish branch and tube polysaccharide and the radix gentianae lutescens extract in the phase C is reduced, although the melanin inhibition rate is improved compared with comparative example 4, the effect is poor compared with examples 1-6 of the invention, comparative example 6, the dosage of the starfish branch and tube polysaccharide and the radix gentianae lutescens extract in the phase C is increased, the removal rate of oil is obviously increased, the face is easy to dry and tight, and the melanin inhibition rate has no obvious change compared with examples 1-6, which shows that the dosage of the starfish branch and tube polysaccharide and the radix gentianae lutescens extract in the cleansing cream of the invention is within the dosage specified in the invention, can effectively inhibit melanin pigmentation, brighten skin color, and achieve the effects of whitening and brightening skin.
In comparative example 7, since behenyl alcohol and polyglycerin-10 stearate were not added to phase B, the spreadability on the facial skin was poor, and it was difficult to remove much oil and fat, the oil and fat removal rate decreased, and the melanin inhibition rate was not greatly affected.
In comparative example 8, as the hydrolyzed sodium hyaluronate is not added in phase A, the free radical scavenging effect and the lipid peroxidation inhibiting effect of the facial cleanser are reduced, so that the oil scavenging rate and the melanin inhibiting rate of the facial cleanser are reduced, which indicates that the hydrolyzed sodium hyaluronate can improve the cleaning power and the whitening and skin-brightening effects of the facial cleanser.
In comparative example 9, the amount of hydrolyzed sodium hyaluronate in phase A is reduced, the efficiency of scavenging free radicals and inhibiting lipid peroxidation is reduced, so that the oil removal rate and the melanin inhibition rate are reduced compared with those in examples 1-6, while in comparative example 10, the amount of hydrolyzed sodium hyaluronate in phase A is increased, the capacity of scavenging free radicals is increased, the oil removal rate is improved, and dry and tight face is easy to appear after face cleaning, but the melanin inhibition rate is not much different from that in examples 1-6, so that the amount of hydrolyzed sodium hyaluronate in the facial cleanser of the invention can be controlled within a specified amount to ensure that the facial cleanser has better cleaning power on dry skin and oily skin, and the water is not tight after face cleaning, so that the pigmentation can be prevented, and the skin color can be improved.
Comparative example 11 is a cleanser prepared by the prior art, which has a large cleansing power for dry skin, easily causes dry and tense facial skin, has an insufficient cleansing power for oily skin, and has a small melanin inhibition rate.
The present embodiment is only for explaining the present invention, and it is not limited to the present invention, and those skilled in the art can make modifications of the present embodiment without inventive contribution as needed after reading the present specification, but all of them are protected by patent law within the scope of the claims of the present invention.
Claims (10)
1. The hyaluronic acid mild moisturizing facial cleanser is characterized by being prepared by mixing a phase A, a phase B and a phase C;
the phase A is prepared from the following raw materials in parts by weight: 58-95 parts of deionized water, 2-16 parts of glycerol, 1-10 parts of butanediol, 0.02-0.8 part of sclerotium rolfsii gum, 0.1-1 part of carbomer, 0.02-0.5 part of hydrolyzed sodium hyaluronate, 0.02-0.15 part of humectant, 0.02-0.8 part of panthenol and 0.02-0.06 part of EDTA disodium;
the phase B is prepared from the following raw materials in parts by weight: 2-12 parts of ethylhexyl palmitate, 0.5-2.5 parts of behenyl alcohol, 1-5 parts of skin conditioning agent, 0.5-5 parts of ethylene glycol distearate, 0.05-3 parts of polysorbate-60, 0.5-3 parts of polyglycerol-10 diisostearate and 0.1-3 parts of polyglycerol-10 stearate;
the phase C is prepared from the following raw materials in parts by weight: 4-20 parts of lauryl glucoside solution, 5-20 parts of lauryl hydroxy sulfobetaine solution, 0.5-1.5 parts of moisturizing antibacterial agent, 0.1-2 parts of gentiana lutea root extracting solution, 0.1-1 part of cladosporium cucumerinum polysaccharide and 0.1-5 parts of PEG-7 sodium olive oil carboxylate.
2. The hyaluronic acid mild moisturizing cleanser according to claim 1, wherein the phase A is prepared from the following raw materials in parts by weight: 65-80 parts of deionized water, 6-12 parts of glycerol, 3-7 parts of butanediol, 0.1-0.6 part of sclerotium rolfsii gum, 0.3-0.6 part of carbomer, 0.1-0.4 part of hydrolyzed sodium hyaluronate, 0.03-0.1 part of humectant, 0.1-0.6 part of panthenol and 0.03-0.06 part of EDTA disodium;
the phase B is prepared from the following raw materials in parts by weight: 4-10 parts of ethylhexyl palmitate, 1-2 parts of behenyl alcohol, 1.8-3 parts of a skin conditioning agent, 1-3 parts of ethylene glycol distearate, 0.1-2 parts of polysorbate-60, 1-2 parts of polyglycerol-10 diisostearate and 0.5-2 parts of polyglycerol-10 stearate;
the phase C is prepared from the following raw materials in parts by weight: 8-17 parts of lauryl glucoside solution, 8-17 parts of lauryl hydroxy sulfobetaine solution, 0.7-1.3 parts of moisturizing antibacterial agent, 0.5-1.5 parts of gentiana lutea root extract, 0.3-0.9 part of cladosporium cucumerinum polysaccharide and 0.5-3 parts of PEG-7 sodium olive oil carboxylate.
3. The hyaluronic acid mild moisturizing cleanser according to any one of claims 1 to 2, wherein the lauryl glucoside liquid is prepared by mixing lauryl glucoside and water in a mass ratio of 4.5-5.5:4.5-5.5 in the phase C;
the lauryl hydroxy sulfobetaine solution comprises, by weight, 28-30 parts of lauryl hydroxy sulfobetaine, 6-8 parts of sodium chloride and 62-76 parts of water.
4. The hyaluronic acid mild moisturizing cleanser of any one of claims 1-2, wherein the gentiana lutea root extract in the C phase comprises, by weight, 72-76 parts of water, 24-26 parts of butanediol and 1-4 parts of gentiana lutea root extract.
5. The hyaluronic acid mild moisturizing cleanser according to any one of claims 1 to 2, wherein the Cladosiphon okamuranus polysaccharide comprises, by weight, 0.3 to 0.6 parts of Cladosiphon okamuranus extract, 24 to 27 parts of phenoxyethanol and 72.4 to 75.7 parts of water.
6. The hyaluronic acid mild moisturizing cleanser according to any one of claims 1 to 2, wherein the moisturizer in the phase A comprises 68 to 72 parts by weight of caprylyl glycol and 28 to 32 parts by weight of ethylhexyl glycerin.
7. The hyaluronic acid mild moisturizing cleanser of any one of claims 1-2, wherein the skin conditioning agent in phase B comprises 80-84 parts by weight of dioctyl lauryl glutamate and 16-20 parts by weight of cetyl stearyl alcohol.
8. The hyaluronic acid mild moisturizing cleanser of any one of claims 1 to 2, wherein the moisturizing antibacterial agent in phase C comprises 15 to 20 parts by weight of glyceryl caprylate, 74 to 81.5 parts by weight of 1, 2-pentanediol and 3.5 to 6 parts by weight of caprylyl hydroxamic acid.
9. A method for preparing hyaluronic acid mild moisturizing cleanser according to any one of claims 1 to 8, comprising the steps of:
s1, mixing the components in the phase A, heating to 78-80 ℃, stirring until the components are completely dissolved, and homogenizing in a homogenizer for 3-10min to obtain a phase A treatment material;
s2, mixing the raw materials in the phase B, heating to 78-85 ℃, and uniformly mixing and stirring to obtain a phase B treatment material;
s3, mixing the phase A treatment material and the phase B treatment material, homogenizing at high speed for 5-8min, keeping the temperature at 78-80 ℃, stirring for 13-15min, stirring and cooling to 60 ℃, adding the mixture of each component in the phase C, and homogenizing for 10-15min to uniformly mix the materials;
and S4, continuously stirring and cooling, vacuumizing simultaneously, and discharging when the temperature is reduced to 37 ℃ to prepare the hyaluronic acid mild moisturizing facial cleanser.
10. The method for preparing hyaluronic acid mild moisturizing facial cleanser according to claim 9, wherein the high-speed homogenizing rotation speed of the phase A treatment material and the phase B treatment material in step S3 is 500-2500 r/min.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911047166.8A CN110652481B (en) | 2019-10-30 | 2019-10-30 | Hyaluronic acid mild moisturizing facial cleanser and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911047166.8A CN110652481B (en) | 2019-10-30 | 2019-10-30 | Hyaluronic acid mild moisturizing facial cleanser and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110652481A true CN110652481A (en) | 2020-01-07 |
CN110652481B CN110652481B (en) | 2022-05-06 |
Family
ID=69042417
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911047166.8A Active CN110652481B (en) | 2019-10-30 | 2019-10-30 | Hyaluronic acid mild moisturizing facial cleanser and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110652481B (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111494236A (en) * | 2020-04-30 | 2020-08-07 | 福州仁量生物制品有限公司 | Facial cleanser, moisturizing lotion and facial mask added with ganoderma lucidum polysaccharide and preparation method thereof |
CN111991258A (en) * | 2020-10-12 | 2020-11-27 | 上海辉文生物技术股份有限公司 | Skin detoxification and oxidation resistance composition and application thereof |
CN115708783A (en) * | 2021-08-23 | 2023-02-24 | 美特瑞生物科技(上海)有限公司 | Formula of liquid crystal emulsifier composition and application of liquid crystal emulsifier composition in cosmetics |
CN115737507A (en) * | 2022-12-16 | 2023-03-07 | 北京植物医生生物科技有限公司 | Stable, skin-friendly and moisturizing facial cleanser and preparation method and application thereof |
CN116570522A (en) * | 2023-05-16 | 2023-08-11 | 广州芃品科技有限公司 | Moisturizing agent, preparation method thereof and cosmetic containing moisturizing agent |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20140349902A1 (en) * | 2011-12-28 | 2014-11-27 | Evonik Industries Ag | Aqueous hair and skin cleaning compositions comprising biosurfactants |
CN109125149A (en) * | 2018-11-07 | 2019-01-04 | 广州无添加主义化妆品有限公司 | A kind of sodium hyaluronate mildy wash and preparation method thereof |
CN109288763A (en) * | 2018-12-05 | 2019-02-01 | 广州睿森生物科技有限公司 | A kind of multi-functional face cleaning cream and preparation method thereof |
CN109453076A (en) * | 2018-09-29 | 2019-03-12 | 广东巴松那生物科技有限公司 | A kind of face cleaning containing ferment admires silk and preparation method thereof |
-
2019
- 2019-10-30 CN CN201911047166.8A patent/CN110652481B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20140349902A1 (en) * | 2011-12-28 | 2014-11-27 | Evonik Industries Ag | Aqueous hair and skin cleaning compositions comprising biosurfactants |
CN109453076A (en) * | 2018-09-29 | 2019-03-12 | 广东巴松那生物科技有限公司 | A kind of face cleaning containing ferment admires silk and preparation method thereof |
CN109125149A (en) * | 2018-11-07 | 2019-01-04 | 广州无添加主义化妆品有限公司 | A kind of sodium hyaluronate mildy wash and preparation method thereof |
CN109288763A (en) * | 2018-12-05 | 2019-02-01 | 广州睿森生物科技有限公司 | A kind of multi-functional face cleaning cream and preparation method thereof |
Non-Patent Citations (2)
Title |
---|
广州美洁日用化工有限公司: "YNT 水漾柔肤洁面乳", 《YNT 水漾柔肤洁面乳》 * |
杭州伊植美化妆品有限公司: "佰娜诗雪颜洁面乳", 《佰娜诗雪颜洁面乳》 * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111494236A (en) * | 2020-04-30 | 2020-08-07 | 福州仁量生物制品有限公司 | Facial cleanser, moisturizing lotion and facial mask added with ganoderma lucidum polysaccharide and preparation method thereof |
CN111991258A (en) * | 2020-10-12 | 2020-11-27 | 上海辉文生物技术股份有限公司 | Skin detoxification and oxidation resistance composition and application thereof |
CN111991258B (en) * | 2020-10-12 | 2022-06-14 | 上海辉文生物技术股份有限公司 | Skin detoxification and oxidation resistance composition and application thereof |
CN115708783A (en) * | 2021-08-23 | 2023-02-24 | 美特瑞生物科技(上海)有限公司 | Formula of liquid crystal emulsifier composition and application of liquid crystal emulsifier composition in cosmetics |
CN115737507A (en) * | 2022-12-16 | 2023-03-07 | 北京植物医生生物科技有限公司 | Stable, skin-friendly and moisturizing facial cleanser and preparation method and application thereof |
CN115737507B (en) * | 2022-12-16 | 2024-05-03 | 北京植物医生生物科技有限公司 | Stable skin-friendly moisturizing facial cleanser and preparation method and application thereof |
CN116570522A (en) * | 2023-05-16 | 2023-08-11 | 广州芃品科技有限公司 | Moisturizing agent, preparation method thereof and cosmetic containing moisturizing agent |
Also Published As
Publication number | Publication date |
---|---|
CN110652481B (en) | 2022-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110652481B (en) | Hyaluronic acid mild moisturizing facial cleanser and preparation method thereof | |
CN110742842B (en) | Essence composition for delaying skin aging and preparation method thereof | |
CN110664685B (en) | Essence emulsion for improving anti-glycation effect of skin and preparation method thereof | |
CN111789777A (en) | Skin care cream with immediate tightening and anti-aging effects and preparation method thereof | |
CN110974720A (en) | Whitening and skin-brightening composition, whitening and skin-brightening cosmetic, whitening and skin-brightening lotion and preparation method thereof, and whitening and skin-brightening emulsion and preparation method thereof | |
CN111588671A (en) | Composition with oil control and convergence effects, cosmetic and application of composition | |
CN110200898B (en) | Multi-effect mask composition and preparation method and application thereof | |
CN110575412A (en) | a special skin caring liquid for pore containing medicinal extract of Fomitopsis pinicola layer, and its preparation method | |
CN110664644B (en) | Skin care composition containing folic acid, essence and preparation method thereof | |
JP2012041302A (en) | Skin cosmetic | |
KR20180094012A (en) | Methods of treating skin conditions and compositions therefor | |
CN111840161A (en) | Anti-aging brightening composition and application and preparation method thereof | |
CN110693776A (en) | Dandruff-removing and itching-relieving scalp essence and preparation method thereof | |
CN112569133A (en) | Firming and anti-wrinkle essence cream and preparation method thereof | |
CN115645293A (en) | Essence oil with antioxidant effect and preparation method and application thereof | |
CN115919733A (en) | Cosmetic composition for removing acne and preparation method thereof | |
CN113925812B (en) | Functional composition for promoting sleep and skin repair and application of functional composition in cosmetics | |
CN114129490B (en) | Sea buckthorn collagen anti-aging moisturizing facial mask and preparation method thereof | |
CN116139060B (en) | Composition with anti-inflammatory and anti-aging effects and preparation method and application thereof | |
CN112494355A (en) | Moisturizing composition and preparation method thereof | |
CN114903810B (en) | Peptide-containing anti-wrinkle composition and application thereof | |
CN116637042A (en) | Wrinkle-removing anti-aging skin care product and preparation method and application thereof | |
CN114288201B (en) | Composition for removing pouch and fading black eye, and preparation method and application thereof | |
CN115054565A (en) | Soothing repair cream for constructing skin barrier | |
CN114246808A (en) | Skin conditioner, oil-controlling and skin-brightening composition and preparation method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220802 Address after: 310000 floor 1-2, building 1, No. 4, Baiye Road, Baizhang Town, Yuhang District, Hangzhou City, Zhejiang Province Patentee after: Zhejiang Yingshu cosmetics technology Co.,Ltd. Address before: 311200 rooms 1701 and 1702, building 2, Wangjing business center, ningwei street, Xiaoshan District, Hangzhou City, Zhejiang Province Patentee before: ZHEJIANG INGLEMIREPHARM'S BIOTECHNOLOGY CO.,LTD. |